Stem Cell Therapy advancements, page-300

Another Aussie pioneering event via UTS and another Aussie stem-cell company:

https://www.sciencedaily.com/releases/2022/06/220616101941.htm

The addition of 3D printing to autologous cell procedures like OCC's ATI and ACI, mean you could literally design cellular delivery according to the affliction. I had a shoulder labrum tear via the company involved above, using Mesenchymal stem cells because the fibrocartilage mix of the tissue meant tenocytes alone would not have been enough - mesenchymal stem cells have the ability to become a variety of tissue cells of course.

Physicians will be able to design, with bio-techs, the cells they want delivered - theoretically you could have a mix of chondrocyte and tenocyte stem-cells designed in accordance with the tissue in the labrum for example.

If this sounds far fetched:

https://www.nano-di.com/newsroom/nano-dimension-files-u-s-patent-application-for-conversion-of-mri-and-ct-scans-for-3d-printing-of-tissues-and-organs

Something interesting whilst we wait for this company to make an "exciting" announcement on the final data from the OrthoATI Phase 2a study, whilst (somewhat understandably) impatient retail continues to sell down the stock.